NCT05970666
- Conditions
- Adebrelimab, Adenocarcinoma, Bevacizumab, +13 more
- Locations
-
- The First Affiliated Hospital of Xiamen University Xiamen, Fujian, China
Clinical trial condition
Explore clinical trials studying Transformation. Study availability and eligibility vary by location and protocol.
NCT05970666